MedPath

Treatment of Early Neuropathy in Leprosy.

Conditions
neuropathy, neuritis, leprosy
Registration Number
NL-OMON22418
Lead Sponsor
Royal Tropical InstituteAmsterdam
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
1250
Inclusion Criteria

Trial 1:

General: All newly diagnosed leprosy patients who can be followed will be eligible for inclusion in the trials.

Exclusion Criteria

General exclusion criteria:

1. Any patient refusing informed consent;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Trial 1:<br /><br>Proportion of patients developing clinical neuropathy as defined by MFT/VMT change.<br><br /><br /><br>Trial 2:<br /><br>Proportion of patients with restored nerve function as measured by MFT/VMT (all nerves).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath